Cullinan Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$17.84

-0.11 (-0.61%)

As of Aug 8, 1:49 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +20.2% upside

Low Target $16.94

Average Target $21.45

High Target $32.37

Current Price $17.84

Current
$17.84

Target
$21.45

$16.94 $21.45 avg $32.37

Scenario Analysis

Bear Case

$16.94

-5.0%

Low target

Base Case

$21.45

+20.2%

Avg target

Bull Case

$32.37

+81.4%

High target

Risk/Reward

16.1x

Highly favorable

Price in Context

52-Week High

$19.43

-8.2% from high

52-Week Low

$5.68

+214.1% from low

Target vs 52W High

$21.45

+10.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%